Actively Recruiting
Diabetes Follow-up Study for Reduction of Cardiovascular Outcomes Using Coronary Computed Tomographic Angiography
Led by Asan Medical Center · Updated on 2026-03-30
511
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the development and progression of coronary atherosclerosis in people with diabetes mellitus using coronary computed tomographic angiography (CCTA). The goal is to understand how this condition changes over time and to identify risk factors related to coronary atherosclerosis in a Korean diabetic population. This observational study follows patients who had an initial CCTA between 2008 and 2012 at the Diabetes Center of the Asan Medical Center. Participants who previously underwent initial CCTA will have follow-up CCTA exams ordered by their primary physicians. Information such as medical history, cardiovascular risk factors, laboratory results, and demographic data were collected at the initial and follow-up CCTA visits. This study does not involve any experimental treatments but monitors changes in coronary atherosclerosis over approximately 10 years. During the study, participants will have their coronary artery condition assessed by comparing their initial and follow-up CCTA scans. Researchers will review clinical data and risk factors to understand disease progression. The main measure is the change in coronary atherosclerosis over about a 10-year period. The study includes ongoing monitoring and data collection to support this evaluation, with total participation spanning from the initial CCTA through follow-up visits as determined by each patient's care provider.
CONDITIONS
Brief Title
A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 years or older
- Asymptomatic patients with type 2 diabetes mellitus who had initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012
- Willing and able to provide informed written consent
You will not qualify if you...
- Blood creatinine level exceeds 1.5 mg/dL
- History of anaphylaxis or allergic shock related to contrast medium
- Pregnant women
- Unable to undergo follow-up CCTA
- Uninterpretable CCTA scans
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Initial evaluation occurred between February 2008 and June 2012; follow-up occurs about 10 years after the initial CCTA.
Participants undergo coronary computed tomographic angiography (CCTA) and have their demographic data, medical history, cardiovascular risk factors, and laboratory data collected.
1 to 2 visits depending on timing of follow-up CCTA
Duration - Approximately 10 years after the first CCTA
Participants are observed over time based on their follow-up CCTA ordered by their primary physician to evaluate changes in coronary atherosclerosis.
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
J
Ji Sue HONG, RN
S
Seung-Whan Lee, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here